HealthMedPage Today
Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek
(MedPage Today) -- In cystic fibrosis, vanzacaftor-tezacaftor-deutivacaftor (VTD; Alyftrek) showed great potential for modifying the progression of disease in young children, according to the TIMBERLINE study. Assessing safety and tolerability...
Join the argument
House rules βComments load as you scroll.